Telitacicept 240mg ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
66	IgA腎症	1

66. IgA腎症

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04905212 (ClinicalTrials.gov)	November 4, 2021	21/5/2021	A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy	A Phase 2, Randomized, Double-Blind, Multicenter Study of Telitacicept for Injection (RC18) With an ...	IgA Nephropathy	Drug: Telitacicept 160mg;Drug: Telitacicept 240mg;Drug: Placebo	RemeGen Co., Ltd.	NULL	Recruiting	18 Years	N/A	All	30	Phase 2	United States

First Previous1Next Last